Anabolic Steroids, Libido and Erectile Function: Effects During and After Use

Anabolic steroids can change libido, erections, orgasm and ejaculation during use and after stopping. A person can feel high desire with poor erections, low desire with normal testosterone on one test, or sexual distress during withdrawal. Symptoms need a timeline, exposure history, selected labs and care that checks vascular, hormonal, mood, sleep and medicine causes.

What sexual function means during and after steroid use

Sexual function is not one switch. Libido is sexual desire. Erectile function is the ability to get and keep an erection firm enough for sex. Orgasm, ejaculation, genital sensation, pain, relationship distress and fertility goals are related but separate topics. A complaint such as “low libido” or “ED” can hide several different problems.

Anabolic androgenic steroids can affect this system through the brain, pituitary gland, testes, blood vessels, mood, sleep and other medicines. During use, some people report higher desire, irritability or confidence while erections stay unreliable. After stopping, low desire, low mood, fatigue, smaller testes and erectile problems can occur as the body tries to restart its own hormone production.

How anabolic steroids can change hormones

The hypothalamic pituitary gonadal axis links the brain, pituitary gland and testes. When outside androgens are used, luteinising hormone and follicle stimulating hormone can fall. That can reduce the testes’ own testosterone production and sperm production. Testicular volume may fall, and semen quality can change even when a person still has sexual desire.

Serum testosterone during active use can be hard to interpret. Some tests measure total testosterone but do not identify the exact nonprescribed compound or product strength. A high value during exposure does not prove normal fertility or normal erectile function. A low value after stopping may reflect suppression, but one isolated test does not define the whole recovery path.

Oestrogen, prolactin, thyroid disease, diabetes, sleep apnea, depression, anxiety, alcohol, opioids, stimulants, finasteride, some antidepressants and blood pressure medicines can also contribute. The medical task is to find the pattern instead of assuming every symptom has one steroid cause.

During use versus after stopping

During AAS exposure, sexual effects may appear mixed. Desire can feel amplified while erections become less predictable. Acne, fluid retention, blood pressure changes, lipid changes, snoring, agitation or pelvic pain may sit beside sexual symptoms. Products bought outside regulated medical care can contain different doses or undeclared ingredients, so label names are poor exposure records.

After stopping, the complaint often shifts toward low desire, fatigue, low mood, erectile difficulty, reduced morning erections or infertility concern. Timing varies. Some people improve over months; some have persistent symptoms and need endocrine or urology care. A fixed “post cycle” calendar cannot confirm recovery for an individual.

Do not use sexual performance as a clearance test. Good erections do not rule out high blood pressure, lipid problems, high hematocrit, liver injury or kidney concerns. Poor erections can be an early cardiovascular signal and deserve direct assessment, especially when chest symptoms, breathlessness, exercise intolerance or fainting occur.

What human research can and cannot tell you

A 2018 survey study of men recruited from bodybuilding forums found reports of erectile dysfunction and libido changes among former and current AAS users, but it was selected, self reported and cross sectional. It helps describe complaints people bring to care; it does not provide a clean risk estimate for every user.

A 2023 systematic review gathered human research on AAS and male infertility or sexual function. The literature includes cohort, case control, cross sectional and case reports with varied exposure histories, coexposures and outcome measures. It supports caution and clinical assessment, but it does not validate a universal home recovery protocol.

Studies of former users also show limits. Cross sectional hormone and symptom findings cannot prove each person’s baseline, exact dose, product contents or future course. Research in women and gender diverse people is more limited, and many papers focus on men seeking bodybuilding effects. That gap should make copy more careful, not more certain.

When symptoms need attention

If symptoms are not an emergency but cause distress, arrange a clinician visit. Low desire, erectile difficulty, painful ejaculation, genital pain, reduced morning erections, breast tenderness, testicular shrinkage, infertility concern, menstrual change or virilising change can each alter the assessment.

History and exam before labs

A useful history records when symptoms started, whether they began during use or after stopping, and which part of sexual function changed. Bring a list of AAS names, forms, approximate start and stop dates, dose estimates if known, injection sites, oral products, ancillaries, erectile dysfunction medicines, stimulants, alcohol, nicotine, recreational drugs and prescription medicines.

Morning erections, erection firmness, orgasm, ejaculation, genital pain, penile curvature, testicular size, breast symptoms, mood, sleep, training load, injury, relationship stress and fertility goals all matter. For women and people with ovaries, menstrual changes, acne, voice change, hair growth, clitoral change, pelvic pain and pregnancy potential also need direct discussion.

Examination can check blood pressure, pulses, genital findings, breast tissue, testicular volume, signs of androgen exposure and signs of other endocrine or vascular disease. Some people feel embarrassed, but a clear exposure history is safer than a vague complaint.

Tests that may be used

Testing depends on symptoms, timing and current exposure. Clinicians may use early morning fasting testosterone measured with a reliable method, repeated on a separate morning when appropriate. Luteinising hormone and follicle stimulating hormone can help separate central suppression from primary testicular disease. Selected free testosterone, sex hormone binding globulin, prolactin, thyroid tests, glucose measures, lipids, blood count, liver markers, kidney markers and urinalysis may be relevant.

A semen analysis is the test that directly assesses sperm count and related semen parameters. Libido, testicle size and semen volume cannot reliably replace it. Fertility planning may need reproductive endocrinology or urology input, especially if pregnancy is desired soon or prior fertility is uncertain.

Do not time labs around a forum protocol. Testing too soon, too late or during an unidentified product exposure can mislead. Bring prior results with units, dates, reference ranges and whether the sample was morning or fasting.

Treatment choices and medicine cautions

Treatment depends on cause. Erectile dysfunction can involve vascular disease, nerve injury, endocrine disease, medicine effects, performance anxiety, pelvic pain or relationship factors. Care may include risk factor review, medicine changes, psychological support, endocrine assessment, urology care or fertility care. A pill alone may miss a signal that needs broader assessment.

Sildenafil and related medicines are not desire medicines and do not protect against pregnancy or sexually transmitted infections. They can be dangerous with nitrates or poppers, and emergency clinicians need to know if they were used. Do not combine erectile dysfunction medicines with unprescribed vasodilators, stimulants or blood pressure products to force performance.

Aromatase inhibitors, selective oestrogen receptor modulators, hCG, cabergoline and testosterone replacement are medical drugs with risks and specific indications. This page does not provide a home restart protocol. If prescribed testosterone is already in use for a diagnosed condition, do not stop or change it without the prescriber’s plan.

Women and gender diverse readers

Most AAS sexual function research has focused on men. That does not make other people immune to harm. In women and people with ovaries, AAS can be associated with menstrual changes, acne, voice deepening, hair growth, clitoral enlargement, mood changes and fertility concerns. Some virilising changes can persist after stopping.

For transgender men and other people using prescribed gender affirming testosterone, nonprescribed AAS exposure is still a separate medical issue. Prescribed hormone care should be discussed with the prescribing clinician, because stopping or adding products can affect mood, bleeding patterns, fertility plans, cardiovascular risk and lab interpretation.

Recovery and follow up

Recovery is individual. Symptoms, hormones, semen parameters and fertility can recover at different speeds. A person may feel better while sperm production remains low, or labs may improve while sexual distress persists. Follow up should match the goal: symptom relief, fertility planning, mental health support, cardiovascular risk reduction or safe cessation.

If symptoms persist, revisit the full picture rather than repeating the same supplement cycle. Consider sleep apnea, depression, anxiety, diabetes, vascular risk, pelvic pain, prostate or urinary symptoms, medicine effects and relationship stress. Read anabolic steroid induced hypogonadism for hormone suppression and anabolic steroids and male fertility for semen and fertility concerns.

Ask a clinician five practical questions: which part of sexual function is being assessed, which tests match the timing, which emergency symptoms should override waiting, when to repeat tests, and who coordinates endocrine, urology, fertility or mental health care.

Related reading

• How to talk with a doctor about anabolic steroid use
• Anabolic steroid warning signs
• Blood tests during anabolic steroid use
• Anabolic steroids and cardiovascular health

References

1. Erection problems. NHS.
2. Priapism. NHS.
3. Testicle pain. NHS.
4. Sildenafil. MedlinePlus.
5. Anabolic androgenic steroids and sexual function. Translational Andrology and Urology, 2018.
6. Anabolic androgenic steroids, male infertility and sexual function. Journal of Human Reproductive Sciences, 2023.
7. Testosterone therapy in men with hypogonadism. Endocrine Society.
8. Former anabolic androgenic steroid users and hypogonadal symptoms. PLOS ONE, 2016.